These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 347106)

  • 41. Double-blind study of levamisole in aphthous stomatitis.
    Kaplan B; Cardarelli C; Pinnell SR
    J Oral Pathol; 1978; 7(6):400-4. PubMed ID: 105099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
    Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The bacillus Calmette-Guérin as immunomodulator in bladder cancer].
    Vázquez-Lavista LG; Flores-Balcázar CH; Llorente L
    Rev Invest Clin; 2007; 59(2):146-52. PubMed ID: 17633803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
    Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial.
    Arnaud JP; Buyse M; Nordlinger B; Martin F; Pector JC; Zeitoun P; Adloff A; Duez N
    Br J Surg; 1989 Mar; 76(3):284-9. PubMed ID: 2655812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
    Spitler LE; Sagebiel R
    N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP
    Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
    Droller MJ
    J Urol; 2001 Feb; 165(2):701-2. PubMed ID: 11233047
    [No Abstract]   [Full Text] [Related]  

  • 49. Re: Agrawal et al.: The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma. (Urology 2007;70:1075-1078).
    Simone G; Leonardo C; Gallucci M
    Urology; 2008 Nov; 72(5):1187-8. PubMed ID: 18774592
    [No Abstract]   [Full Text] [Related]  

  • 50. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of patients with pT1 stage non-muscle-invasive bladder cancer.
    Ajili F; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Aug; 37(4):278-83. PubMed ID: 23789613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer.
    Matsumoto K; Kikuchi E; Shirakawa H; Hayakawa N; Tanaka N; Ninomiya A; Miyajima A; Nakamura S; Oya M
    BJU Int; 2012 Dec; 110(11 Pt B):E508-13. PubMed ID: 22574662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.
    Saluja M; Gilling P
    Int J Urol; 2018 Jan; 25(1):18-24. PubMed ID: 28741703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
    Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
    Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 59. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
    Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
    Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind study of levamisole therapy in recurrent aphthous stomatitis.
    Olson JA; Silverman S
    J Oral Pathol; 1978; 7(6):393-9. PubMed ID: 105098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.